vs

Side-by-side financial comparison of Forian Inc. (FORA) and TriSalus Life Sciences, Inc. (TLSI). Click either name above to swap in a different company.

TriSalus Life Sciences, Inc. is the larger business by last-quarter revenue ($13.2M vs $8.0M, roughly 1.7× Forian Inc.). Forian Inc. runs the higher net margin — -22.9% vs -73.9%, a 51.0% gap on every dollar of revenue. On growth, TriSalus Life Sciences, Inc. posted the faster year-over-year revenue change (59.8% vs 37.0%). Over the past eight quarters, TriSalus Life Sciences, Inc.'s revenue compounded faster (43.0% CAGR vs 27.8%).

Forian Inc is a specialized healthcare technology and data analytics firm offering SaaS-based real-world evidence solutions, clinical decision support tools, and operational optimization services. It serves biopharmaceutical companies, healthcare providers, and life sciences stakeholders to improve patient outcomes, accelerate research, and boost care delivery efficiency.

TriSalus Life Sciences, Inc. is a clinical-stage biotechnology company focused on advancing immuno-oncology and interventional oncology solutions. It develops proprietary targeted drug delivery technologies designed to improve treatment efficacy for patients with liver, pancreatic and other hard-to-treat solid tumors, primarily operating in North American markets via partnerships with clinical care and research institutions.

FORA vs TLSI — Head-to-Head

Bigger by revenue
TLSI
TLSI
1.7× larger
TLSI
$13.2M
$8.0M
FORA
Growing faster (revenue YoY)
TLSI
TLSI
+22.9% gap
TLSI
59.8%
37.0%
FORA
Higher net margin
FORA
FORA
51.0% more per $
FORA
-22.9%
-73.9%
TLSI
Faster 2-yr revenue CAGR
TLSI
TLSI
Annualised
TLSI
43.0%
27.8%
FORA

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
FORA
FORA
TLSI
TLSI
Revenue
$8.0M
$13.2M
Net Profit
$-1.8M
$-9.8M
Gross Margin
49.2%
86.7%
Operating Margin
-24.4%
-24.8%
Net Margin
-22.9%
-73.9%
Revenue YoY
37.0%
59.8%
Net Profit YoY
-1012.2%
3.5%
EPS (diluted)
$-0.06
$-0.22

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
FORA
FORA
TLSI
TLSI
Q4 25
$8.0M
$13.2M
Q3 25
$7.8M
$11.6M
Q2 25
$7.5M
$11.2M
Q1 25
$7.1M
$9.2M
Q4 24
$5.8M
$8.3M
Q3 24
$4.7M
$7.3M
Q2 24
$4.8M
$7.4M
Q1 24
$4.9M
$6.5M
Net Profit
FORA
FORA
TLSI
TLSI
Q4 25
$-1.8M
$-9.8M
Q3 25
$-151.2K
$-10.8M
Q2 25
$224.8K
$-8.3M
Q1 25
$-1.1M
$-10.4M
Q4 24
$199.7K
$-10.1M
Q3 24
$-204.9K
$-2.4M
Q2 24
$-2.6M
$-4.3M
Q1 24
$-1.2M
$-13.2M
Gross Margin
FORA
FORA
TLSI
TLSI
Q4 25
49.2%
86.7%
Q3 25
51.6%
83.5%
Q2 25
56.8%
83.9%
Q1 25
55.6%
83.7%
Q4 24
58.3%
85.3%
Q3 24
70.1%
86.3%
Q2 24
62.2%
87.6%
Q1 24
65.1%
85.0%
Operating Margin
FORA
FORA
TLSI
TLSI
Q4 25
-24.4%
-24.8%
Q3 25
-6.1%
-77.9%
Q2 25
0.6%
-65.4%
Q1 25
-19.8%
-79.9%
Q4 24
-24.9%
-91.8%
Q3 24
-17.0%
-118.9%
Q2 24
-62.2%
-111.0%
Q1 24
-36.3%
-180.8%
Net Margin
FORA
FORA
TLSI
TLSI
Q4 25
-22.9%
-73.9%
Q3 25
-1.9%
-93.5%
Q2 25
3.0%
-73.9%
Q1 25
-16.0%
-113.2%
Q4 24
3.4%
-122.4%
Q3 24
-4.4%
-32.6%
Q2 24
-53.4%
-58.8%
Q1 24
-24.9%
-204.5%
EPS (diluted)
FORA
FORA
TLSI
TLSI
Q4 25
$-0.06
$-0.22
Q3 25
$0.00
$-0.96
Q2 25
$0.01
$-0.27
Q1 25
$-0.04
$-0.39
Q4 24
$0.01
$-0.38
Q3 24
$-0.01
$-0.12
Q2 24
$-0.08
$-0.21
Q1 24
$-0.04
$-0.60

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
FORA
FORA
TLSI
TLSI
Cash + ST InvestmentsLiquidity on hand
$31.6M
$20.4M
Total DebtLower is stronger
Stockholders' EquityBook value
$29.8M
$-33.9M
Total Assets
$44.1M
$35.3M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
FORA
FORA
TLSI
TLSI
Q4 25
$31.6M
$20.4M
Q3 25
$28.2M
$22.7M
Q2 25
$35.6M
$26.5M
Q1 25
$35.7M
$13.0M
Q4 24
$35.1M
$8.5M
Q3 24
$49.4M
$11.3M
Q2 24
$48.0M
$16.5M
Q1 24
$47.4M
$4.0M
Stockholders' Equity
FORA
FORA
TLSI
TLSI
Q4 25
$29.8M
$-33.9M
Q3 25
$31.1M
$-26.7M
Q2 25
$30.9M
$-19.4M
Q1 25
$30.0M
$-34.4M
Q4 24
$30.1M
$-25.9M
Q3 24
$28.4M
$-20.4M
Q2 24
$27.2M
$-25.3M
Q1 24
$28.1M
$-36.0M
Total Assets
FORA
FORA
TLSI
TLSI
Q4 25
$44.1M
$35.3M
Q3 25
$41.3M
$36.5M
Q2 25
$48.5M
$41.3M
Q1 25
$48.6M
$28.6M
Q4 24
$47.2M
$24.0M
Q3 24
$57.5M
$27.5M
Q2 24
$58.4M
$32.4M
Q1 24
$57.5M
$17.9M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
FORA
FORA
TLSI
TLSI
Operating Cash FlowLast quarter
$3.2M
$-2.5M
Free Cash FlowOCF − Capex
$-2.5M
FCF MarginFCF / Revenue
-19.1%
Capex IntensityCapex / Revenue
0.3%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-19.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
FORA
FORA
TLSI
TLSI
Q4 25
$3.2M
$-2.5M
Q3 25
$-439.7K
$-3.7M
Q2 25
$-344.5K
$-7.3M
Q1 25
$448.2K
$-4.5M
Q4 24
$1.7M
$-5.7M
Q3 24
$764.1K
$-10.8M
Q2 24
$-23.1K
$-13.4M
Q1 24
$-2.2M
$-10.9M
Free Cash Flow
FORA
FORA
TLSI
TLSI
Q4 25
$-2.5M
Q3 25
$-3.9M
Q2 25
$-7.4M
Q1 25
$-5.3M
Q4 24
$-5.8M
Q3 24
$-11.0M
Q2 24
$-13.5M
Q1 24
$-10.9M
FCF Margin
FORA
FORA
TLSI
TLSI
Q4 25
-19.1%
Q3 25
-33.9%
Q2 25
-66.1%
Q1 25
-57.3%
Q4 24
-69.7%
Q3 24
-149.9%
Q2 24
-183.1%
Q1 24
-169.3%
Capex Intensity
FORA
FORA
TLSI
TLSI
Q4 25
0.3%
Q3 25
1.9%
Q2 25
0.8%
Q1 25
8.2%
Q4 24
0.0%
0.6%
Q3 24
0.0%
2.3%
Q2 24
0.0%
0.8%
Q1 24
0.0%
1.0%
Cash Conversion
FORA
FORA
TLSI
TLSI
Q4 25
Q3 25
Q2 25
-1.53×
Q1 25
Q4 24
8.76×
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

FORA
FORA

Financial Services Revenues$7.3M92%
Other$669.0K8%

TLSI
TLSI

Segment breakdown not available.

Related Comparisons